Hepatitis B

San Francisco Hepatitis B Quality Improvement Collaborative (QIC)
Improving the quality of care - from screening to specialty treatment - for patients at risk for and infected with chronic Hepatitis B

San Francisco has a high prevalence of chronic Hepatitis B. One third of San Francisco residents are Asian, half of whom are born outside the US in countries with high rates of vertical transmission of Hepatitis B.
The San Francisco Department of Public Health, Asian Week Foundation and other community groups have actively supported and promoted a SF Hep B Free Campagin to encourage the Asian community to be screened for Hepatitis B.
The screening campaign has uncovered major gaps in quality of care in San Francisco for managing patients who test positive for chronic Hepatitis B.
CTSI in partnership with the SF Hep B Free Campaign has created a Hep B Quality Improvement Collaborative to facilitate a cooperative, citywide effort in San Francisco among physician and health care organizations to systematically improve processes for Hepatitis B screening and clinical care. All major medical groups in SF are participating in the collaborative, including Kaiser, Individual Practice Associations (IPAs), and safety net clinics.
Creating of a citywide registry of patients with Hepatitis B will be a key element for both improving quality of care and health outcomes for patients with Hepatitis B and enhancing clinical and comparative effectiveness research in Hepatitis B.

Hepatitis B Quality Improvement Collaborative (QIC) Participants
Navigator: Paula Fleisher

AsianWeek Foundation
Brown and Toland Medical Group
Chinese Community Health Care Association
Chinese Hospital
Hill Physicians Medical Group
Kaiser Permanente
SF Community Clinic Consortium | Northeast Medical Services
SF Department of Public Health | Communicable Disease Control and Prevention
SF Department of Public Health | Community Health Network
SF Hep B Free Campaign
UCSF CTSI Community Engagement and Health Policy Program
UCSF Medical Center
UCSF School of Pharmacy

An
Initiative
of

This website was supported by NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.